Article    Table of Contents                    Full Text of this article Free    PDF of this article    Summary for Patients    Summary for Patients (PDF)    Figures/Tables List    Recommendation Summary    Related articles in Annals    CME course  Services    Related Clinical Content    Send comment/rapid response letter    Published comments/rapid response letters    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search    Get Permissions  Google Scholar    Search for Related Content  Social Bookmarking

What's this?

PubMed

Related Articles in PubMed    PubMed Citation    PubMed

CLINICAL GUIDELINES

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

U.S. Preventive Services Task Force^*

5 August 2008 | Volume 149 Issue 3 | Pages 185-191

Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer.

Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen–detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation.

Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement).

Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).

Author and Article Information

---

From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.

Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Financial Support: The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov).

^* For a list of Task Force members, see the Appendix.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

Related articles in Annals:

Clinical Guidelines
Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force
Kenneth Lin, Robert Lipsitz, Therese Miller, AND Supriya Janakiraman

Annals 2008 149: 192-199. [ABSTRACT][SUMMARY][Full Text]  

Summaries for Patients
Screening for Prostate Cancer with Prostate-Specific Antigen Testing: U.S. Preventive Services Task Force Recommendations

Annals 2008 149: I-37. [Full Text]  

Letters
Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening?
Badrinath R. Konety, Matthew R. Cooperberg, AND Peter R. Carroll

Annals 2009 150: 220-221. [Full Text]  

Letters
Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening?
Manfred Gogol

Annals 2009 150: 221. [Full Text]  

Letters
Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening?
Ned Calonge, Diana B. Petitti, AND Kenneth W. Lin

Annals 2009 150: 221-222. [Full Text]  

This article has been cited by other articles:

				M. R. Cooperberg, J. M. Broering, and P. R. Carroll Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis J Natl Cancer Inst, June 16, 2009; 101(12): 878 - 887. [Abstract] [Full Text] [PDF]

				S. V. Hudson, P. Ohman-Strickland, J. M. Ferrante, G. Lu-Yao, A. J. Orzano, and B. F. Crabtree Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices J Am Board Fam Med, May 1, 2009; 22(3): 257 - 265. [Abstract] [Full Text] [PDF]

				M. J. Barry Screening for Prostate Cancer -- The Controversy That Refuses to Die N. Engl. J. Med., March 26, 2009; 360(13): 1351 - 1354. [Full Text] [PDF]

				G. L. Andriole, E. D. Crawford, R. L. Grubb III, S. S. Buys, D. Chia, T. R. Church, M. N. Fouad, E. P. Gelmann, P. A. Kvale, D. J. Reding, et al. Mortality Results from a Randomized Prostate-Cancer Screening Trial N. Engl. J. Med., March 26, 2009; 360(13): 1310 - 1319. [Abstract] [Full Text] [PDF]

				M. Gogol Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening? Ann Intern Med, February 3, 2009; 150(3): 221 - 221. [Full Text] [PDF]

				B. R. Konety, M. R. Cooperberg, and P. R. Carroll Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening? Ann Intern Med, February 3, 2009; 150(3): 220 - 221. [Full Text] [PDF]

				N. Calonge, D. B. Petitti, and K. W. Lin Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening? Ann Intern Med, February 3, 2009; 150(3): 221 - 222. [Full Text] [PDF]

				R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin, January 1, 2009; 59(1): 27 - 41. [Abstract] [Full Text] [PDF]

				O. W. Brawley, S. Lucia, and G. Andriole Chemoprevention of Prostate Cancer ASCO Educational Book, January 1, 2009; 2009(1): 62 - 64. [Abstract] [Full Text] [PDF]

				J. E. Montie, M. A. Carducci, and D. A. Kuban Perspectives on the Management of Localized Prostate Cancer: Focus on Radiotherapy ASCO Educational Book, January 1, 2009; 2009(1): 270 - 274. [Abstract] [Full Text] [PDF]

				M. J. Barry Screening for Prostate Cancer among Men 75 Years of Age or Older N. Engl. J. Med., December 11, 2008; 359(24): 2515 - 2516. [Full Text] [PDF]

				C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers Clin. Chem., December 1, 2008; 54(12): e11 - e79. [Abstract] [Full Text] [PDF]

				USPSTF Recommends Against Screening for Prostate Cancer in Older Men Journal Watch (General), August 26, 2008; 2008(826): 1 - 1. [Full Text]

Rapid Responses: